Notably, studies have revealed that the reduction in serum IL-10 levels in obese individuals probably results from the decreased production of IL-10 from the spleen, implying that spleen-derived IL-10 plays a vital role in the prevention of obesity-induced chronic inflammation [27, 28]. Here, IL10 is linked to obesity disorder.